NEW YORK, Oct. 7 /PRNewswire/ -- NGN Capital LLC, a global healthcare venture capital investment firm, today announced the appointment of Peter Johann, Ph.D. as General Partner. The former Head of Corporate Division Corporate Development at Boehringer Ingelheim, Dr. Johann brings extensive experience in the pharmaceutical and healthcare industry to NGN Capital and will play a key role in supporting the investment efforts of the firm.
“We are extremely pleased to have Peter join our Heidelberg office,” said Georg Nebgen, a Founder and Managing General Partner at NGN Capital. “Peter has a powerful background in establishing alliances in the healthcare industry. His expertise ideally complements our seasoned team and will be very valuable to the success of our firm, which is primarily focused on later- stage investments.”
Dr. Johann has more than 15 years’ experience in the pharmaceutical and health care industry in corporate and business development, licensing, M&A, strategic planning, marketing and sales. He has established a global network within the pharmaceutical and biotechnology industry and led a worldwide operating team. In his position as Division Head for Corporate Development at Boehringer Ingelheim and in previous functions, he was involved in numerous licensing and co-promotion/co-marketing and M&A deals. Previously, he was a Global Business Leader at Hoffmann La-Roche, and Head of Business Development and Marketing, Molecular Medicine, at Boehringer Mannheim. In these positions, he gained additional expertise in establishing and managing joint venture companies and in establishing and managing collaborations in the field of biopharmaceuticals.
“I am excited to be joining such a strong group of healthcare and investment professionals with substantial value creation achievements and commercial expertise,” stated Dr. Johann. “I look forward to investing in healthcare opportunities and supporting portfolio companies of NGN Capital in operational, strategic and partnering issues.”
NGN Capital is a global healthcare venture capital investment firm with offices in New York, NY, Heidelberg, Germany, and Greenwich, CT. NGN has investment capabilities across a broad spectrum of healthcare and biotechnology segments, including drug products, medical devices, and healthcare services, with an emphasis on later-stage opportunities. More information on NGN can be found at http://www.ngncapital.com/.
NGN Capital LLC
CONTACT: John R. Costantino, NGN Capital LLC, +1-212-351-5001,jcostantino@ngncapital.com
Web site: http://www.ngncapital.com/